masticillin
virbac new zealand limited - penicillin g procaine - penicillin g procaine 500 g/litre - antibiotic
intracillin 1000 milking cow
virbac new zealand limited - penicillin g procaine - penicillin g procaine 287 g/kg - antibiotic
lactacillin
virbac new zealand limited - penicillin g procaine - penicillin g procaine 266.67 g/kg - antibiotic
mastipen
virbac new zealand limited - penicillin g procaine - penicillin g procaine 266.67 g/kg - antibiotic
aerotet forte
virbac new zealand limited - gentian violet; oxytetracycline hydrochloride - gentian violet 4 g/litre; oxytetracycline hydrochloride 53 g/litre - antibiotic
elevet+ ampiclox l.c. lactating cow intramammary antibiotic infusion
avet health limited - ampicillin as the sodium salt; cloxacillin as the sodium salt - misc. intra mammary - ampicillin as the sodium salt antibiotic active 75.0 mg/3gsy; cloxacillin as the sodium salt antibiotic active 200.0 mg/3gsy - antibiotic & related - cattle lactating | bovine - corynebacterium pyogenes | escherichia coli (e. coli) | staphylococci | streptococci | including b-lactamase producin
elevet+ juraclox l.c. lactating cow intramammary antibiotic infusion
avet health limited - ampicillin as the sodium salt; cloxacillin as the sodium salt - misc. intra mammary - ampicillin as the sodium salt antibiotic active 75.0 mg/3gsy; cloxacillin as the sodium salt antibiotic active 200.0 mg/3gsy - antibiotic & related - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - mastitis | subclinical mastitis
ampicillin- ampicillin injection, powder, for suspension
gc hanford manufacturing company - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin 25 g - ampicillin for injectable suspension has proved effective in the treatment of many infections previously beyond the spectrum of penicillin therapy. this drug is particularly indicated in the treatment of the following infections caused by susceptible strains of organisms: dogs and cats - respiratory tract infections: upper respiratory infections, tonsillitis and bronchopneumonia due to hemolytic streptococci, staphylococcus aureus, escherichia coli, proteus mirabilis and pasteurella spp. urinary tract infections due to proteus mirabilis, escherichia coli, staphylococcus spp., hemolytic streptococci and enterococcus spp. gastrointestinal infections due to enterococcus spp., staphylococcus spp. and escherichia coli . skin, soft tissue and post-surgical infections: abscesses, pustular dermatitis, cellulitis and infections of the anal gland, due to escherichia coli, proteus mirabilis , hemolytic streptococci, staphylococcus spp. and pasteurella spp. cattle and calves including non-ruminating (veal cal
ampicillin sodium- ampicillin sodium injection, powder, for solution
gc hanford manufacturing company - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 1 g - ampicillin sodium is indicated in the treatment of susceptible strains of the organisms causing the following infections in the horse: respiratory tract infections (pneumonia and strangles) due to staphylococcus spp., streptococcus spp. (including s. equi ), e. coli, and proteus mirabilis . skin and soft tissue infections (abscesses and wounds) due to staphylococcus spp., streptococcus spp., e. coli , and proteus mirabilis. as with all antibiotics, appropriate in vitro culturing and susceptibility testing of samples taken before treatment should be conducted. the use of this drug is contraindicated in animals with a history of an allergic reaction to penicillin.
ampicillin and sulbactam- ampicillin sodium and sulbactam sodium injection, powder, for solution
sandoz inc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin 1 g - ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus, escherichia coli*, klebsiella spp.* (including k. pneumoniae* ), proteus mirabilis*, bacteroides fragilis*, enterobacter spp. *, and acinetobacter calcoaceticus*. note: for information on use in pediatric patients (see precautions - pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli, klebsiella spp. (including k. pneumoniae*) , bacteroides spp. (including b. fragilis ), and enterobacter spp.* gynecological infections caused by beta-lactamase producing strains of escherichia coli*, and bacteroides spp.* (including b. fragilis* ). *efficacy for this organism in this organ system was studied in fewer than 10 infections. while ampicillin and s